​

eFFECTOR Therapeutics (EFTR) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

eFFECTOR Therapeutics Revenue Highlights

00

Main Segment (Y)

Grant Revenue

Main Geography (Y)

Grant Revenue

eFFECTOR Therapeutics Revenue by Period

eFFECTOR Therapeutics Revenue by Year

DateRevenueChange
2023-12-31--100.00%
2022-12-31$3.55M148.46%
2021-12-31$1.43M-96.60%
2020-12-31$42.00M100.00%
2019-12-31--

eFFECTOR Therapeutics generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

eFFECTOR Therapeutics Revenue by Quarter

DateRevenueChange
2024-03-31--100.00%
2023-12-31$162.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31--100.00%
2022-12-31$675.00K-22.15%
2022-09-30$867.00K-56.89%
2022-06-30$2.01M100.00%
2022-03-31--100.00%
2021-12-31$1.43M234.89%
2021-09-30$427.00K100.00%
2021-06-30-100.00%
2021-03-31--100.00%
2020-12-31$42.00K-92.68%
2020-09-30$574.00K-

eFFECTOR Therapeutics generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

eFFECTOR Therapeutics Revenue Breakdown

eFFECTOR Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 21
Grant Revenue$1.43M
Collaboration Revenue-

eFFECTOR Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 21: Grant Revenue (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 22Dec 21Sep 21
D A R P A Grant$2.00M--
Grant Revenue-$311.00K$427.00K
Collaboration Revenue---

eFFECTOR Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Jun 22: D A R P A Grant (100.00%).

eFFECTOR Therapeutics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 21
Collaboration Revenue-
Grant Revenue$1.43M

eFFECTOR Therapeutics's latest annual revenue breakdown by geography, as of Dec 21: Grant Revenue (100.00%).

Quarterly Revenue by Country

CountryJun 22Dec 21Sep 21
D A R P A Grant$2.00M--
Grant Revenue-$311.00K$427.00K
Collaboration Revenue---

eFFECTOR Therapeutics's latest quarterly revenue breakdown by geography, as of Jun 22: D A R P A Grant (100.00%).

eFFECTOR Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ENSCEnsysce Biosciences$2.23M-
RNXTRenovoRx--
VRPXVirpax Pharmaceuticals--
INDPIndaptus Therapeutics--
JSPRJasper Therapeutics--

EFTR Revenue FAQ

What is eFFECTOR Therapeutics’s yearly revenue?

eFFECTOR Therapeutics's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $3.55M, representing an increase of 148.46% compared to 2021. EFTR's yearly revenue for 2021 was $1.43M, representing a decrease of -96.60% compared to 2020.

What is eFFECTOR Therapeutics’s quarterly revenue?

eFFECTOR Therapeutics's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $162K, a 100.00% increase from the previous quarter (Q3 2023), and a -76.00% decrease year-over-year (Q4 2022). EFTR's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a -100.00% decrease year-over-year (Q3 2022).

What is eFFECTOR Therapeutics’s revenue growth rate?

eFFECTOR Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -100.00%, and for the last 5 years (2019-2023) was 0%.

What are eFFECTOR Therapeutics’s revenue streams?

eFFECTOR Therapeutics's revenue streams in c 21 are Grant Revenue

What is eFFECTOR Therapeutics’s main source of revenue?

For the fiscal year ending Dec 21, the largest source of revenue of eFFECTOR Therapeutics was Grant Revenue. This segment made a revenue of $1.43M, representing 100.00% of the company's total revenue.